[糖尿病病中免疫相关转录因子的生物信息分析]
Li Liu1, Jiaojiao Yang2, Jianmin Ren3
1Department of Endocrinology, Zaozhuang Central District People's Hospital, Zaozhuang 277100, China.
概括
这项研究确定了糖尿病病 (DKD) 患者的关键免疫相关转录因子,揭示了基于免疫疗法的潜在标. 这些因素与功能相关,为DKD治疗提供了新的途径.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 生物信息学是一种生物信息学.
背景情况:
- 糖尿病病 (DKD) 涉及复杂的免疫失调.
- 识别特定的与免疫相关的基因和转录因子 (TFs) 对于理解DKD病变的产生至关重要.
研究的目的:
- 通过生物信息学分析,在DKD患者的球体和管中识别与免疫相关的转录因子 (TF).
- 探索已识别的TF与DKD的临床病理特征之间的相关性.
主要方法:
- 使用了基因表达数据集 (GEO,RNA-seq) 和生物信息学工具 (Limma,DESeq2,GSEA).
- 进行了差异表达,共同表达和蛋白质与蛋白质相互作用 (PPI) 网络分析.
- 使用Nephroseq数据库将确定的TF与临床数据相关联.
主要成果:
- 与对照人群相比,在DKD球体和管体中发现了显著的免疫基因表达差异.
- 在质细胞中确定了9个关键TF (例如,IRF8,RUNX3) 和41个管状细胞 (例如,FOSB,NR4A1,IRF8,STAT1).
- 关键的TFs与DKD患者的淋巴细胞过率 (GFR) 有显著的相关性.
结论:
- 生物信息学分析成功地确定了潜在的与免疫相关的TFs,这些TFs与DKD病变产生有关.
- 这些TF与DKD的免疫失调和功能有关.
- 对这些TF的进一步研究可能会导致DKD的新型基于免疫的治疗策略.
相关概念视频
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...